A Chinese-developed sequencing assay measuring donor-derived cell-free DNA identified a 0.33% threshold for detecting acute rejection in heart transplant recipients, offering a noninvasive alternative to biopsy.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.